Scientists have found that preserving lymph nodes during cancer surgery could dramatically improve how patients respond to ...

Details: This summit organized by Oppenheimer & Co. in partnership with the University of Miami Sylvester Cancer Center, focuses on oncology advancements, offering Medicenna a platform to discuss its ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational ...

(UroToday.com) The 2025 European Society of Medical Oncology (ESMO) Annual Congress held in Berlin, Germany between September 17 th and 21 st was host to the session Mini oral session: GU tumours, ...

胰腺癌（Pancreatic Cancer）以胰腺导管腺癌（PDAC）最为常见，具有起病隐匿、早期转移、对化疗/免疫治疗敏感性差的特点，长期总体生存率低，仍是肿瘤学中预后最差的实体瘤之一。

ORR and 79% DCR observed in heavily pretreated TMB-H or MSI-H/dMMR tumors across six major solid tumor types, including colorectal, lung, breast, ...

Lila Sciences' already impressive $235 million first round financing has continued to build and has now closed at $350 ...

The skin, as the body’s largest organ, serves as a dynamic interface between internal systems and environmental influences.

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...